US 11,813,294 B2
Methods for the treatment of autism spectrum disorders
Joanne Kurtzberg, Durham, NC (US); Geraldine Dawson, Durham, NC (US); Jesse Troy, Durham, NC (US); and Jessica Sun, Durham, NC (US)
Assigned to DUKE UNIVERSITY, Durham, NC (US)
Filed by DUKE UNIVERSITY, Durham, NC (US)
Filed on Feb. 8, 2021, as Appl. No. 17/170,373.
Application 17/170,373 is a continuation of application No. 16/493,754, granted, now 10,912,801, previously published as PCT/US2018/022174, filed on Mar. 13, 2018.
Claims priority of provisional application 62/470,431, filed on Mar. 13, 2017.
Prior Publication US 2021/0244772 A1, Aug. 12, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 35/14 (2015.01); A61K 35/51 (2015.01); A61B 5/16 (2006.01); A61P 43/00 (2006.01); A61B 5/055 (2006.01); A61B 5/00 (2006.01); A61K 9/00 (2006.01); A61B 5/369 (2021.01)
CPC A61K 35/51 (2013.01) [A61B 5/055 (2013.01); A61B 5/163 (2017.08); A61B 5/369 (2021.01); A61B 5/4848 (2013.01); A61K 9/0019 (2013.01); A61P 43/00 (2018.01)] 13 Claims
OG exemplary drawing
 
1. A method of treating a patient suffering from an autism spectrum disorder, comprising administering to the patient a therapeutically effective amount of cord blood such that the disease is treated, wherein the amount of cord blood administered comprises 2×107 to 3=×108 cord blood cells/kg of body weight.